Affiliation:
1. Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, PR China.
Abstract
Rationale:
Male secretory breast cancer is a rare, low-grade carcinoma, especially in boys. Due to its rarity, not much is known about this disease.
Patient concerns:
A 5-year-old boy presented with a 1.4 cm painless mass in the right breast.
Diagnoses:
Ultrasonography could not distinguish whether the breast tumor was benign or malignant. After a biopsy of the lumpectomy specimen, it was diagnosed to be secretory breast carcinoma.
Interventions:
The patient underwent a modified radical mastectomy for his right breast. No postoperative chemotherapy or radiotherapy was performed. Next-generation sequencing of 211 cancer-related genes was detected, and the results revealed an ETV6-NTRK3 translocation and a PDGFRB c.2632A > G mutation. None of the most commonly altered molecules in male aggressive breast cancer (such as BRCA1-2, TP53, RAD51C, and RAD51D mutations) has been identified.
Outcomes:
The patient was still free from local recurrence or metastases at 6-month follow-up.
Lessons:
The genomic profile of male pediatric SCB is relatively simple, no other known driver genes have been found except for the ETV6-NTRK3 fusion. Our report will improve our understanding of secretory breast cancer.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference25 articles.
1. Advancement of secretory breast carcinoma: a narrative review.;Min;Ann Transl Med,2022
2. Breast tumours in infants and children: a 40-year review of cases at a children’s hospital.;Simpson;Can Med Assoc J,1969
3. Secretory carcinoma of the breast.;Tavassoli;Cancer,1980
4. Secretory breast carcinoma with metastatic sentinel lymph node.;Vieni;World J Surg Oncol,2006
5. Secretory breast carcinoma in a 9-year-old boy.;Titus;Aust N Z J Surg,2000